Aperture Investors, LLC - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 46 filers reported holding FINCH THERAPEUTICS GROUP INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Aperture Investors, LLC ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q3 2022$322,000
-45.4%
192,794
-7.2%
0.05%
-45.9%
Q2 2022$590,000
-39.9%
207,729
+6.4%
0.10%
-22.8%
Q1 2022$982,000
-49.5%
195,2290.0%0.13%
-49.2%
Q4 2021$1,946,000
-35.5%
195,229
-15.8%
0.25%
-38.3%
Q3 2021$3,016,000
-32.8%
231,991
-27.3%
0.40%
-21.1%
Q2 2021$4,490,000
-39.9%
319,122
-32.0%
0.51%
-55.2%
Q1 2021$7,471,000469,5841.15%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q3 2021
NameSharesValueWeighting ↓
Avenir Management Company, LLC 1,663,366$2,778,0004.72%
TRB Advisors LP 570,000$952,0000.94%
Bleichroeder LP 810,416$1,353,0000.28%
LAKE STREET ADVISORS GROUP, LLC 739,136$1,234,0000.09%
Ikarian Capital, LLC 237,553$397,0000.08%
Oasis Management Co Ltd. 225,000$376,0000.06%
Aperture Investors, LLC 192,794$322,0000.05%
MSD Partners, L.P. 388,691$649,0000.05%
Proficio Capital Partners LLC 110,559$185,0000.03%
Baupost Group 1,123,108$1,876,0000.03%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders